在先前冠状动脉旁路移植的患者中,跨导管与外科 mitra 门干预
Mahmoud Ismayl1, Hasaan Ahmed2, Andrew M Goldsweig3
1Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN, USA.
概括
过导管 mitra 干预越来越多地用于先前冠状动脉旁路移植的患者,与手术方法相比,显示出类似的死亡率和再入院率.
科学领域:
- 心血管医学 心血管医学
- 干预心脏病学 干预心脏病学
- 心脏外科手术 心脏外科手术
背景情况:
- 许多需要米特拉 (MV) 干预的患者有冠状动脉旁路移植 (CABG) 的病史.
- 重复手术心脏手术具有较高的风险.
研究的目的:
- 为了比较过导管与手术MV干预的利用和结果,在以前有过CABG的患者中进行MV干预.
- 在这个高风险人群中评估微创方法的安全性和有效性.
主要方法:
- 全国再接收数据库 (2016-2021) 的分析.
- 包括先前经过CABG的成年患者,经过过导管或手术MV干预.
- 使用多变量回归,倾向匹配和Cox比例危险模型比较住院结果和再入院.
主要成果:
- 从2016年到2021年,过导管MV干预在之前有过CABG的患者中显著增加.
- 类似的住院死亡率和180天心力衰竭再入院被观察到跨导管与手术MV干预.
- 透导管方法与较低的中风率,急性损伤,永久性起器安置,较短的停留时间和较少的非家庭出院有关,但更高的血管并发症随着更换.
结论:
- 过导管MV干预正在成为先前CABG患者的首选选择.
- 这些程序在死亡率和心力衰竭再入院方面显示出与手术干预相比的安全性和有效性.
相关概念视频
Mitral Valve Prolapse II: Assessment and Management
1.4K
IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
1.4K
Mitral Regurgitation III: Medical Management
689
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
689
Mitral Stenosis II: Clinical features and Diagnostic Tests
564
Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
564
Mitral Stenosis III: Medical Management
538
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
538
Mitral Stenosis IV: Nursing Management
425
A comprehensive nursing assessment is essential for patients with valvular heart disease, which involves any dysfunction of the heart valves that could impact blood flow and overall heart function.Subjective Data Collection:Chief Complaint and Present Illness: Start with the patient's primary concerns, focusing on the onset, duration, and progression of cardiac symptoms such as dyspnea, fatigue, chest pain, and palpitations.Past Medical History: Collect detailed information on any previous...
425
Aortic Regurgitation III: Medical Management
598
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
598


